Overview
the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.
Description
Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until now. However,this two type therapies were controversial. The study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.
Eligibility
Inclusion Criteria:
non-invasive prolactionma
Exclusion Criteria:
invasive prolactioma